Wed, August 28, 2024
[ Wed, Aug 28th 2024
] - WOPRAI
Tue, August 13, 2024
[ Tue, Aug 13th 2024
] - WOPRAI
Mon, August 5, 2024
[ Mon, Aug 05th 2024
] - WOPRAI
Thu, June 13, 2024
[ Thu, Jun 13th 2024
] - WOPRAI
Thu, May 30, 2024
[ Thu, May 30th 2024
] - WOPRAI
Thu, May 23, 2024
[ Thu, May 23rd 2024
] - WOPRAI
Tue, May 21, 2024
[ Tue, May 21st 2024
] - WOPRAI
Tue, May 14, 2024
[ Tue, May 14th 2024
] - WOPRAI
Thu, May 2, 2024
[ Thu, May 02nd 2024
] - WOPRAI
Wed, April 17, 2024
[ Wed, Apr 17th 2024
] - WOPRAI
Mon, April 15, 2024
[ Mon, Apr 15th 2024
] - WOPRAI
Wed, April 3, 2024
[ Wed, Apr 03rd 2024
] - WOPRAI
Tue, March 26, 2024
[ Tue, Mar 26th 2024
] - WOPRAI
Fri, January 5, 2024
[ Fri, Jan 05th 2024
] - WOPRAI
Wed, November 15, 2023
[ Wed, Nov 15th 2023
] - WOPRAI
Fri, August 18, 2023
[ Fri, Aug 18th 2023
] - WOPRAI
Wed, August 2, 2023
[ Wed, Aug 02nd 2023
] - WOPRAI
Thu, June 8, 2023
[ Thu, Jun 08th 2023
] - WOPRAI
Fri, May 26, 2023
[ Fri, May 26th 2023
] - WOPRAI
Tue, May 23, 2023
[ Tue, May 23rd 2023
] - WOPRAI
Tue, May 2, 2023
[ Tue, May 02nd 2023
] - WOPRAI
Tue, April 11, 2023
[ Tue, Apr 11th 2023
] - WOPRAI
Wed, March 29, 2023
[ Wed, Mar 29th 2023
] - WOPRAI
Mon, March 27, 2023
[ Mon, Mar 27th 2023
] - WOPRAI
Thu, March 9, 2023
[ Thu, Mar 09th 2023
] - WOPRAI
Wed, March 1, 2023
[ Wed, Mar 01st 2023
] - WOPRAI
Thu, November 17, 2022
[ Thu, Nov 17th 2022
] - WOPRAI
Fri, November 11, 2022
[ Fri, Nov 11th 2022
] - WOPRAI
Thu, November 3, 2022
[ Thu, Nov 03rd 2022
] - WOPRAI
Mon, April 4, 2022
[ Mon, Apr 04th 2022
] - WOPRAI
Hartaj Singh Maintained (UTHR) at Buy with Increased Target to $575 on, Aug 28th, 2024
Hartaj Singh of Oppenheimer, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $400 to $575 on, Aug 28th, 2024.
Hartaj has made no other calls on UTHR in the last 4 months.
There are 8 other peers that have a rating on UTHR. Out of the 8 peers that are also analyzing UTHR, 2 agree with Hartaj's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Terence Flynn of "Morgan Stanley" Downgraded from Buy to Hold and Increased Target to $321 on, Thursday, July 11th, 2024
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Increased Target to $240 on, Friday, May 3rd, 2024
These are the ratings of the 6 analyists that currently disagree with Hartaj
- Tiago Fauth of "Wells Fargo" Maintained at Buy with Increased Target to $380 on, Tuesday, August 20th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $400 on, Thursday, August 1st, 2024
- Greg Harrison of "B of A Securities" Maintained at Sell with Decreased Target to $280 on, Thursday, August 1st, 2024
- Joseph Thome of "TD Cowen" Maintained at Strong Buy with Increased Target to $350 on, Thursday, July 11th, 2024
- Ashwani Verma of "UBS" Maintained at Strong Buy with Increased Target to $370 on, Monday, July 8th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $300 on, Tuesday, May 21st, 2024
Contributing Sources